The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...
Axios Login on MSN4d
Bain may bail on Fuji Soft pursuit, after new KKR bidBain Capital disclosed that it is considering the "option of withdrawing" its hostile $4.2 billion takeover bid for Japanese ...
Carlyle is wrapping up a two-year fundraising campaign for its eighth secondaries flagship, CEO Harvey Schwartz said on the ...
The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...
TOKYO -- Japan's Mitsubishi Chemical Group announced on Friday the agreed sale of its pharmaceutical subsidiary, Mitsubishi ...
Foreign investment firms like Bain Capital have been riding a growing wave of Japanese mergers and acquisitions in recent years as big companies spin off noncore businesses or company managements ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback